CAM
GMAB icon

Cresset Asset Management’s Genmab GMAB Stock Holding History

Cresset Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,468
Closed -$244K – 1583
2025
Q1 		$244K Sell
12,468
-13,284
-52% -$279K ﹤0.01% 1432
2024
Q4 		$537K Sell
25,752
-33,523
-57% -$737K ﹤0.01% 1056
2024
Q3 		$1.45M Buy
59,275
+10,766
+22% +$288K 0.01% 982
2024
Q2 		$1.22M Sell
48,509
-1,447
-3% -$41K 0.01% 966
2024
Q1 		$1.49M Buy
49,956
+4,108
+9% +$121K 0.01% 795
2023
Q4 		$1.46M Sell
45,848
-7,417
-14% -$233K 0.01% 724
2023
Q3 		$1.86M Buy
53,265
+23,685
+80% +$903K 0.01% 584
2023
Q2 		$1.12M Buy
+29,580
New +$1.18M ﹤0.01% 888
2022
Q1 		– Sell
-16,718
Closed -$661K – 1050
2021
Q4 		$661K Sell
16,718
-3,033
-15% -$126K 0.01% 596
2021
Q3 		$864K Buy
19,751
+5,116
+35% +$230K 0.01% 441
2021
Q2 		$598K Buy
14,635
+3,881
+36% +$150K 0.01% 505
2021
Q1 		$353K Buy
10,754
+5,274
+96% +$198K 0.01% 599
2020
Q4 		$223K Buy
+5,480
New +$205K ﹤0.01% 672

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Cresset Asset Management's GMAB Position: Q2 2025 in Review

Cresset Asset Management sold out of Genmab (GMAB) in Q2 2025, closing a stake of 12,468 shares — an estimated $244K sold.

Cresset Asset Management first reported a position in GMAB in Q4 2020 and held it in 13 quarters. The position peaked at $1.86M in Q3 2023. 217 funds tracked by Wall St. Rank hold GMAB as of Q2 2025.

  • Cresset Asset Management reported no remaining Genmab position as of Q2 2025 after selling out during the quarter.
  • Cresset Asset Management sold 12,468 Genmab shares in Q2 2025, an estimated $244K.
  • Cresset Asset Management first reported a position in Genmab in Q4 2020 and held it in 13 quarters.
  • Cresset Asset Management's Genmab position peaked at $1.86M in Q3 2023.
  • 217 funds tracked by Wall St. Rank held Genmab as of Q2 2025.

Based on Cresset Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.